ABPI Pharma Impact Map

CF supported The Association of the British Pharmaceutical Industry (ABPI) in developing a tool that maps the impact of the biopharmaceutical industry at a local area, across the four nations. The aim was to quantify the industry’s impact at a local level, bringing together multiple sources of information to allows members of the public, policymakers and other interested groups to explore the contribution the industry makes to the UK economy and health system at a local level.

What was the challenge?

The ABPI represents pharmaceutical companies of all sizes which invest in making and discovering medicines and vaccines to enhance and save the lives of millions of people around the world. The ABPI exists to make the UK the best place in the world to research, develop and access medicines and vaccines to improve patient care.

Every day the ABPI and its members partner with healthcare professionals, policymakers, academics and patient organisations to find new solutions to unmet health need and support the growth of the industry in the UK. To do this effectively, the ABPI sought to showcase the local level impact of the biopharmaceutical industry. There are vast amounts of publicly available data regarding the industry’s contribution at a national, regional, and local level, but this can be hard to access, combine or visualise.

What did we do?

Pulled data from various sources and constructed metrics to measure the impact of the biopharmaceutical industry across the UK.
Quantified the industry’s impact in three key areas: the economy, NHS and industry collaborations, and research.
Developed an interactive mapping tool with a postcode-level search function, enabling users to view the industry’s impact at a national, regional, and constituency level.
Compiled this data and insights into a comprehensive resource to improve awareness and support informed policymaking among politicians, officials, healthcare leaders, and the general public.

What was the impact?

The Pharma Impact Map, leveraging public data, benefits the general public, policymakers, and interested individuals seeking to understand the biopharmaceutical industry’s local-level contribution to the UK economy and healthcare system.
The Pharma Impact Map was presented to key government officials, including members of parliament, ministers, and policymakers, providing them with local-level insights into the biopharmaceutical industry’s economic and social impact.